Clinical Trials Directory

Trials / Completed

CompletedNCT01652365

Feasibility and Impact of Malaria Rapid Diagnostic Tests in the African Retail Sector

Evaluation of the Feasibility and Impact of Introducing Malaria Rapid Diagnostic Tests in the Retail Sector: A Randomized Controlled Trial in Eastern Uganda

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2,800 (actual)
Sponsor
Harvard School of Public Health (HSPH) · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess the feasibility and impact of introducing subsidized malaria rapid diagnostic tests (RDTs) into retail sector drug shops in Uganda. This is a randomized controlled trial at the village level, taking place in 6 districts in Eastern Uganda. Licensed drug shops in selected villages were trained in proper RDT storage, administration, interpretation and disposal and were given access to subsidized RDTs for sale. This study explores whether drug shop owners--when given access to training and subsidized RDTs--will choose to promote and sell RDTs to customers and, if so, at what volume and what price. The investigators also explore whether shops will safely store, administer, interpret and dispose of RDTs and to what extent they will use RDT results to guide treatment recommendations. Finally, the study explores whether making RDTs available for sale in local drug shops has a community level impact on diagnostic testing and appropriate treatment for malaria.

Conditions

Interventions

TypeNameDescription
BEHAVIORALRDT Training and Subsidy Offered
BEHAVIORALInformation/Education Campaign

Timeline

Start date
2011-03-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2012-07-30
Last updated
2012-07-30

Locations

2 sites across 1 country: Uganda

Source: ClinicalTrials.gov record NCT01652365. Inclusion in this directory is not an endorsement.